The JCO Podcast hosted by Dr. Shannon Westin features discussions of new and noteworthy results publ
Tailoring treatment in intermediate-risk pediatric Hodgkin lymphoma is feasible using an early respo
Given the high rate of unplanned hospitalizations in older cancer patients, multidisciplinary care i
Minimal residual disease monitoring has been very helpful in early response evaluation and risk stra
This podcast describes the report of a cohort of Chinese patients with known prior hepatitis B expos
In this paper, the authors demonstrate that only a very small percentage of patients from 2 large, p
A phase I/II study of the antibody-drug conjugate glembatumumab vedotin (CDX-011 or CR011-vcMMAE) in
Conventional GVHD prophylaxis with calcineurin inhibitors has a high incidence of chronic GVHD. Kana
Many new oncology drugs are expensive. Drug prices may not reflect the whole cost of new agents, as
This podcast discusses a phase 2 trial of cabozantinib in men with advanced bone-metastatic prostate
This podcast discusses the results and practical implications of a population-based study that found
This podcast discusses the current state of knowledge regarding allogeneic transplantation as a trea
This study assessed diabetes mellitus risk in long-term Hodgkin lymphoma survivors, and found that a
This podcast reviews the publication of the RESORT manuscript, and puts these results into context w
This podcast will use the study reported by Bejar and colleagues to review the role of screening for
This JCO Podcast provides observations and commentary on the JCO article, "Oncology Fellows' Career
This study reports surprisingly good outcomes for children with Ph-like ALL treated on the St. Jude
Corticosteroids are recommended as part of the WHO analgesic ladder but there is limited evidence fo
The availability of reconstructive surgeons restricts the use of immediate breast reconstruction, cr
This podcast describes the rising epidemic of HPV-associated oropharynx cancer, its unique demograph
This podcast discusses the report of cardiac monitoring data from the HERA trial, places the finding
